1. Home
  2. VRAR vs OKYO Comparison

VRAR vs OKYO Comparison

Compare VRAR & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRAR
  • OKYO
  • Stock Information
  • Founded
  • VRAR 2016
  • OKYO 2007
  • Country
  • VRAR United States
  • OKYO United Kingdom
  • Employees
  • VRAR N/A
  • OKYO N/A
  • Industry
  • VRAR Retail: Computer Software & Peripheral Equipment
  • OKYO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • VRAR Technology
  • OKYO Health Care
  • Exchange
  • VRAR Nasdaq
  • OKYO Nasdaq
  • Market Cap
  • VRAR 33.3M
  • OKYO 37.0M
  • IPO Year
  • VRAR 2021
  • OKYO 2022
  • Fundamental
  • Price
  • VRAR $1.33
  • OKYO $2.43
  • Analyst Decision
  • VRAR Strong Buy
  • OKYO Strong Buy
  • Analyst Count
  • VRAR 1
  • OKYO 1
  • Target Price
  • VRAR $2.62
  • OKYO $7.00
  • AVG Volume (30 Days)
  • VRAR 139.2K
  • OKYO 213.3K
  • Earning Date
  • VRAR 05-15-2025
  • OKYO 08-12-2025
  • Dividend Yield
  • VRAR N/A
  • OKYO N/A
  • EPS Growth
  • VRAR N/A
  • OKYO N/A
  • EPS
  • VRAR N/A
  • OKYO N/A
  • Revenue
  • VRAR $8,756,789.00
  • OKYO N/A
  • Revenue This Year
  • VRAR $6.59
  • OKYO N/A
  • Revenue Next Year
  • VRAR $30.43
  • OKYO N/A
  • P/E Ratio
  • VRAR N/A
  • OKYO N/A
  • Revenue Growth
  • VRAR N/A
  • OKYO N/A
  • 52 Week Low
  • VRAR $0.50
  • OKYO $0.81
  • 52 Week High
  • VRAR $7.00
  • OKYO $3.11
  • Technical
  • Relative Strength Index (RSI)
  • VRAR 45.22
  • OKYO 58.47
  • Support Level
  • VRAR $1.28
  • OKYO $2.05
  • Resistance Level
  • VRAR $1.53
  • OKYO $2.56
  • Average True Range (ATR)
  • VRAR 0.11
  • OKYO 0.32
  • MACD
  • VRAR -0.03
  • OKYO -0.01
  • Stochastic Oscillator
  • VRAR 22.27
  • OKYO 48.50

About VRAR The Glimpse Group Inc.

The Glimpse Group Inc is a diversified Virtual and Augmented Reality platform company, comprised of multiple VR and AR software and services companies, and designed with the specific purpose of cultivating companies in the emerging VR/AR industry.

About OKYO OKYO Pharma Limited

OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.

Share on Social Networks: